Abnormal movements in critical care patients with brain injury: A diagnostic approach

Critical Care

Volumn 20, Issue 1, 2016, Pages

  Hannawi, Yousef ^a,b   Abers, Michael S ^c   Geocadin, Romergryko G ^a,d   Mirski, Marek A ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMFEBUTAMONE; AMIODARONE; AMPHETAMINE; AMPHOTERICIN; AUTOANTIBODY; CARBAMAZEPINE; CARBAPENEM; CEPHALOSPORIN; CIMETIDINE; CLOZAPINE; COCAINE; DIATRIZOATE; DIGOXIN; HALOPERIDOL; LEVOTHYROXINE; LINEZOLID; LITHIUM; METOCLOPRAMIDE; NEUROLEPTIC AGENT; PETHIDINE; PHENYTOIN; PROCAINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

AKATHISIA; ATAXIA; BRAIN DEATH; BRAIN HEMORRHAGE; BRAIN HYPOXIA; BRAIN INFECTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN TUMOR; CHOREA; CHOREA MINOR; CLONUS; COMA; DIAGNOSTIC TEST; DYSKINESIA; DYSTONIA; ELECTROENCEPHALOGRAM; ENCEPHALITIS; EPILEPTIC STATE; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; METABOLIC ENCEPHALOPATHY; MOTOR DYSFUNCTION; MYOCLONUS; NEUROLEPTIC MALIGNANT SYNDROME; NYSTAGMUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEIZURE; SUBARACHNOID HEMORRHAGE; TARDIVE DYSKINESIA; TRAUMATIC BRAIN INJURY; TREMOR; COMPLICATION; DIFFERENTIAL DIAGNOSIS; DYSKINESIAS; ELECTROENCEPHALOGRAPHY; PROCEDURES; SEIZURES;

BRAIN INJURIES; COMA; CRITICAL CARE; DIAGNOSIS, DIFFERENTIAL; DYSKINESIAS; ELECTROENCEPHALOGRAPHY; HUMANS; INTENSIVE CARE UNITS; SEIZURES;

EID: 84978924363     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-016-1236-2     Document Type: Review

References (97)

1. Wijdicks EF, Hijdra A, Young GB, Bassetti CL, Wiebe S, Quality Standards Subcommittee of the American Academy of Nuerology. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;67:203-10.
2. Venkatesan A, Frucht S. Movement disorders after resuscitation from cardiac arrest. Neurologic Clin. 2006;24:123-32.
3. Mirski MA, Varelas PN. Seizures and status epilepticus in the critically ill. Crit Care Clin. 2008;24:115-47. ix.
4. Benbadis SR, Chen S, Melo M. What's shaking in the ICU? The differential diagnosis of seizures in the intensive care setting. Epilepsia. 2010;51:2338-40.
5. Fahn SJJ, Hallet M, Jenner P. Priniciples and practive of movement disorders. Philadelphia: Churchill Livingstone; 2007.
6. Beghi E, Regio V, Papantonio A, Bentivoglio AR, Fasano A, Fogli D, et al. Reliability of clinical diagnosis of dystonia. Neuroepidemiology. 2014;43:213-9.
7. Logroscino G, Livrea P, Anaclerio D, Aniello MS, Benedetto G, Cazzato G, et al. Agreement among neurologists on the clinical diagnosis of dystonia at different body sites. J Neurol Neurosurg Psychiatry. 2003;74:348-50.
8. Sierra-Hidalgo F, Romero JP, Bermejo-Pareja F, et al. Inter-rater agreement in the clinical diagnosis of essential tremor: data from the NEDICES-2 Pilot Study. Tremor Other Hyperkinet Mov (N Y). 2014;4:tre-04-187-4774-3.
9. Bateman DE. Neurological assessment of coma. J Neurol Neurosurg Psychiatry. 2001;71 Suppl 1:i13-7.
10. Bauer G, Trinka E. Nonconvulsive status epilepticus and coma. Epilepsia. 2010;51:177-90.
11. Alfonsi P. Postanaesthetic shivering. Epidemiology, pathophysiology and approaches to prevention and management. Minerva Anestesiol. 2003;69:438-42.
12. Walther S, Strik W. Motor symptoms and schizophrenia. Neuropsychobiology. 2012;66:77-92.
13. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin N Am. 1993;77:185-202.
14. Alarcon F, Gimenez-Roldan S. Systemic diseases that cause movement disorders. Parkinsonism Relat Disord. 2005;11:1-18.
15. Alarcon F, Zijlmans JC, Duenas G, Cevallos N. Post-stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry. 2004;75:1568-74.
16. Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Coté R, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57:1617-22.
17. Varelas P. Seizures in critical care: a guide to diagnosis and therapeutics. 2nd ed. New York: Humana Press; 2010.
18. Pozos RS, Israel D, McCutcheon R, Wittmers Jr LE, Sessler D. Human studies concerning thermal-induced shivering, postoperative "shivering," and cold-induced vasodilation. Ann Emerg Med. 1987;16:1037-41.
19. Hirsch LJ, Pang T, Claassen J, Chang C, Khaled KA, Wittman J, et al. Focal motor seizures induced by alerting stimuli in critically ill patients. Epilepsia. 2008;49:968-73.
20. Stevens RD, Bhardwaj A. Approach to the comatose patient. Crit Care Med. 2006;34:31-41.
21. Towne AR, Waterhouse EJ, Boggs JG, Garnett LK, Brown AJ, Smith Jr JR, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology. 2000;54:340-5.
22. Wijdicks EF, Varelas PN, Gronseth GS, Greer DM, American Academy of Neurology. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74:1911-8.
23. Saposnik G, Basile VS, Young GB. Movements in brain death: a systematic review. Can J Neurol Sci. 2009;36:154-60.
24. Jung KY, Han SG, Lee KH, Chung CS. Repetitive leg movements mimicking periodic leg movement during sleep in a brain-dead patient. Eur J Neurol. 2006;13:e3-4.
25. Ropper AH. Unusual spontaneous movements in brain-dead patients. Neurology. 1984;34:1089-92.
26. Ziai WC, Kaplan PW. Seizures and status epilepticus in the intensive care unit. Semin Neurol. 2008;28:668-81.
27. Claassen J, Taccone FS, Horn P, Holtkamp M, Stocchetti N, Oddo M, et al. Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. Intensive Care Med. 2013;39:1337-51.
28. Hirsch LJ, Claassen J, Mayer SA, Emerson RG. Stimulus-induced rhythmic, periodic, or ictal discharges (SIRPIDs): a common EEG phenomenon in the critically ill. Epilepsia. 2004;45:109-23.
29. Frucht S, Fahn S. The clinical spectrum of posthypoxic myoclonus. Mov Disord. 2000;15 Suppl 1:2-7.
30. Logan A, Sangkachand P, Funk M. Optimal management of shivering during therapeutic hypothermia after cardiac arrest. Crit Care Nurse. 2011;31:e18-30.
31. Mani R, Schmitt SE, Mazer M, Putt ME, Gaieski DF. The frequency and timing of epileptiform activity on continuous electroencephalogram in comatose post-cardiac arrest syndrome patients treated with therapeutic hypothermia. Resuscitation. 2012;83:840-7.
32. Wijdicks EF, Parisi JE, Sharbrough FW. Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol. 1994;35:239-43.
33. Hui AC, Cheng C, Lam A, Mok V, Joynt GM. Prognosis following postanoxic myoclonus status epilepticus. Eur Neurol. 2005;54:10-3.
34. Young GB, Gilbert JJ, Zochodne DW. The significance of myoclonic status epilepticus in postanoxic coma. Neurology. 1990;40:1843-8.
35. Khot S, Tirschwell DL. Long-term neurological complications after hypoxic-ischemic encephalopathy. Semin Neurol. 2006;26:422-31.
36. Bhatt MH, Obeso JA, Marsden CD. Time course of postanoxic akinetic-rigid and dystonic syndromes. Neurology. 1993;43:314-7.
37. Virmani T, Greene PE, Pearson TS. Delayed onset of progressive chorea after acute basal ganglia injury. Mov Disord. 2013;28:585-7.
38. Krauss JK, Pohle T, Borremans JJ. Hemichorea and hemiballism associated with contralateral hemiparesis and ipsilateral basal ganglia lesions. Mov Disord. 1999;14:497-501.
39. Ropper AH. Hyperosmolar therapy for raised intracranial pressure. N Engl J Med. 2012;367:746-52.
40. Diringer MN, Bleck TP, Claude Hemphill 3rd J, Menon D, Shutter L, Vespa P, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15:211-40.
41. Ghika-Schmid F, Ghika J, Regli F, Bogousslavsky J. Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry. J Neurol Sci. 1997;146:109-16.
42. Bansil S, Prakash N, Kaye J, Wrigley S, Manata C, Stevens-Haas C, et al. Movement disorders after stroke in adults: a review. Tremor Other Hyperkinet Mov (N Y). 2012;2:tre-02-42-195-1.
43. Mehanna R, Jankovic J. Movement disorders in cerebrovascular disease. Lancet Neurol. 2013;12:597-608.
44. Devinsky O, Kelley K, Porter RJ, Theodore WH. Clinical and electroencephalographic features of simple partial seizures. Neurology. 1988;38:1347-52.
45. Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL, Chestnut RM, et al. Guidelines for the management of severe traumatic brain injury. XIII. Antiseizure prophylaxis. J Neurotrauma. 2007;24 Suppl 1:S83-6.
46. Lump D, Moyer M. Paroxysmal sympathetic hyperactivity after severe brain injury. Curr Neurol Neurosci Rep. 2014;14:494.
47. O'Suilleabhain P, Dewey Jr RB. Movement disorders after head injury: diagnosis and management. J Head Trauma Rehabil. 2004;19:305-13.
48. Krauss JK, Jankovic J. Head injury and posttraumatic movement disorders. Neurosurgery. 2002;50:927-39. discussion 39-40.
49. Wang DW, Yin YM, Yao YM. Advances in the management of acute liver failure. World J Gastroenterol. 2013;19:7069-77.
50. Barrett KM. Neurologic manifestations of acute and chronic renal disease. Continuum. 2011;17:45-55.
51. Harris MK, Elliott D, Schwendimann RN, Minagar A, Jaffe SL. Neurologic presentations of hepatic disease. Neurologic Clin. 2010;28:89-105.
52. Hirsch KG, Josephson SA. An update on neurocritical care for the patient with kidney disease. Adv Chronic Kidney Dis. 2013;20:39-44.
53. Barton B, Zauber SE, Goetz CG. Movement disorders caused by medical disease. Semin Neurol. 2009;29:97-110.
54. Young RR, Shahani BT. Asterixis: one type of negative myoclonus. Adv Neurol. 1986;43:137-56.
55. Oh SH, Lee KY, Im JH, Lee MS. Chorea associated with non-ketotic hyperglycemia and hyperintensity basal ganglia lesion on T1-weighted brain MRI study: a meta-analysis of 53 cases including four present cases. J Neurol Sci. 2002;200:57-62.
56. Newman RP, Kinkel WR. Paroxysmal choreoathetosis due to hypoglycemia. Arch Neurol. 1984;41:341-2.
57. Yen DJ, Shan DE, Lu SR. Hyperthyroidism presenting as recurrent short paroxysmal kinesigenic dyskinesia. Mov Disord. 1998;13:361-3.
58. Isaacs JD, Rakshi J, Baker R, Brooks DJ, Warrens AN. Chorea associated with thyroxine replacement therapy. Mov Disord. 2005;20:1656-7.
59. Kang EG, Jeon SJ, Choi SS, Song CJ, Yu IK. Diffusion MR imaging of hypoglycemic encephalopathy. Am J Neuroradiol. 2010;31:559-64.
60. Tambyah PA, Ong BK, Lee KO. Reversible parkinsonism and asymptomatic hypocalcemia with basal ganglia calcification from hypoparathyroidism 26 years after thyroid surgery. Am J Med. 1993;94:444-5.
61. Strawn JR, Keck Jr PE, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164:870-6.
62. Velamoor VR, Norman RM, Caroff SN, Mann SC, Sullivan KA, Antelo RE. Progression of symptoms in neuroleptic malignant syndrome. J Nervous Mental Dis. 1994;182:168-73.
63. Iqbal MM, Basil MJ, Kaplan J, Iqbal MT. Overview of serotonin syndrome. Ann Clin Psychiatry. 2012;24:310-8.
64. Haddad PM, Das A, Ashfaq M, Wieck A. A review of valproate in psychiatric practice. Expert Opin Drug Metab Toxicol. 2009;5:539-51.
65. Friedman LS, Weinrauch LA, D'Elia JA. Metoclopramide-induced neuroleptic malignant syndrome. Arch Internal Med. 1987;147:1495-7.
66. Dressler D, Benecke R. Diagnosis and management of acute movement disorders. J Neurol. 2005;252:1299-306.
67. Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf. 2002;25:91-110.
68. Morgan JC, Sethi KD. Drug-induced tremors. Lancet Neurol. 2005;4:866-76.
69. Murphy K, Delanty N. Drug-induced seizures. CNS Drugs. 2000;14:135-46.
70. Bhidayasiri R, Truong DD. Chorea and related disorders. Postgrad Med J. 2004;80:527-34.
71. Baizabal-Carvallo JF, Jankovic J. Movement disorders in autoimmune diseases. Mov Disord. 2012;27:935-46.
72. Pfister HW, Feiden W, Einhaupl KM. Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch Neurol. 1993;50:575-81.
73. Murthy S, Keystone J, Kissoon N. Infections of the developing world. Crit Care Clin. 2013;29:485-507.
74. Sarrazin JL, Bonneville F, Martin-Blondel G. Brain infections. Diagn Interv Imaging. 2012;93:473-90.
75. Michael BD, Solomon T. Seizures and encephalitis: clinical features, management, and potential pathophysiologic mechanisms. Epilepsia. 2012;53 Suppl 4:63-71.
76. Sejvar JJ, Marfin AA. Manifestations of West Nile neuroinvasive disease. Rev Med Virol. 2006;16:209-24.
77. Alarcon F, Maldonado JC, Rivera JW. Movement disorders identified in patients with intracranial tuberculomas. Neurologia. 2011;26:343-50.
78. Alarcon F, Duenas G, Cevallos N, Lees AJ. Movement disorders in 30 patients with tuberculous meningitis. Mov Disord. 2000;15:561-9.
79. Tschampa HJ, Herms JW, Schulz-Schaeffer WJ, Maruschak B, Windl O, Jastrow U, et al. Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology. Brain. 2002;125:2558-66.
80. Garg RK, Karak B, Misra S. Neurological manifestations of malaria: an update. Neurol India. 1999;47:85-91.
81. Nash TE, Mahanty S, Loeb JA, Theodore WH, Friedman A, Sander JW, et al. Neurocysticercosis: a natural human model of epileptogenesis. Epilepsia. 2015;56:177-83.
82. Baizabal-Carvallo JF, Bonnet C, Jankovic J. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm (Vienna). 2013;120:1579-89.
83. Baizabal-Carvallo JF, Stocco A, Muscal E, Jankovic J. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord. 2013;28:543-7.
84. Hannawi Y, Hannawi B, Rao CP, Suarez JI, Bershad EM. Stroke-associated pneumonia: major advances and obstacles. Cerebrovasc Dis. 2013;35:430-43.
85. Chamorro A, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol. 2012;8:401-10.
86. Davis R, Dalmau J. Autoimmunity, seizures, and status epilepticus. Epilepsia. 2013;54 Suppl 6:46-9.
87. Rosenfeld MR, Titulaer MJ, Dalmau J. Paraneoplastic syndromes and autoimmune encephalitis: five new things. Neurol Clin Practice. 2012;2:215-23.
88. Rosenfeld MR, Dalmau J. Paraneoplastic neurologic disorders: a brief overview. Memo. 2012;5:197-200.
89. Hannawi Y, Goldsmith CE, Kass JS, Olar A, Ubogu EE, Kalkonde YV. A case of severe chronic progressive axonal polyradiculoneuropathy temporally associated with anti-CV2/CRMP5 antibodies. J Clin Neuromusc Dis. 2013;15:13-8.
90. Serratrice G, Serratrice J. Continuous muscle activity, Morvan's syndrome and limbic encephalitis: ionic or non ionic disorders? Acta Myol. 2011;30:32-3.
91. Mocellin R, Walterfang M, Velakoulis D. Hashimoto's encephalopathy: epidemiology, pathogenesis and management. CNS Drugs. 2007;21:799-811.
92. Batchelor T, DeAngelis LM. Medical management of cerebral metastases. Neurosurg Clin N Am. 1996;7:435-46.
93. Lacy J, Saadati H, Yu JB. Complications of brain tumors and their treatment. Hematol Oncol Clin N Am. 2012;26:779-96.
94. Thomas JE, Reagan TJ, Klass DW. Epilepsia partialis continua. A review of 32 cases. Arch Neurol. 1977;34:266-75.
95. Bhatoe HS. Movement disorders caused by brain tumours. Neurol India. 1999;47:40-2.
96. Jr B. Stupor and Coma. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, editors. Neurology in clinical practice. Philadelphia: Elsevier; 2008. p. 39-58.
97. Sutter R, Stevens RD, Kaplan PW. Continuous electroencephalographic monitoring in critically ill patients: indications, limitations, and strategies. Crit Care Med. 2013;41:1124-32.